News

News Subscription

Nov 15. 2016
Basilea's antifungal Cresemba® (isavuconazole) launched in France
Read more
Download
Sep 20. 2016
Basilea announces distribution agreement with Unimedic for CRESEMBA® (isavuconazole) and Zevtera® (ceftobiprole) in the Nordic countries
Read more
Download
Sep 15. 2016
Basilea announces partnership for antifungal isavuconazole in Japan with Asahi Kasei Pharma
Read more
Download
Sep 13. 2016
Basilea announces supply, distribution and license agreement with Grupo Biotoscana for CRESEMBA® (isavuconazole) and Zevtera® (ceftobiprole) in Latin America
Read more
Download
Sep 06. 2016
Basilea starts continuous infusion phase 1/2a clinical study with oncology drug candidate BAL101553
Read more
Download
Aug 17. 2016
Basilea announces distribution agreement with Hikma for CRESEMBA® (isavuconazole) in the MENA region
Read more
Download
Aug 15. 2016
Basilea reports 2016 half-year results - CRESEMBA® launched in key European markets
Read more
Download
Jun 27. 2016
Basilea's antifungal CRESEMBA® (isavuconazole) launched in Italy
Read more
Download
Jun 09. 2016
Basilea reports presentation of data on clinical oncology programs BAL101553 and BAL3833 at ASCO meeting
Read more
Download
Apr 22. 2016
Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders
Read more
Download